Jonathan Zung
Corporate Officer/Principal chez CURIS, INC.
Fortune : - $ au 31/03/2024
Provenance du réseau au premier degré de Jonathan Zung
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
14
| Public Company | Biotechnology | 14 |
12
| Public Company | Pharmaceuticals: Major | 12 |
| Subsidiary | Pharmaceuticals: Major | 8 | |
Clinical Data Interchange Standards Consortium, Inc.
 Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021.
4
| Non-Profit Organization | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jonathan Zung via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Services to the Health Industry | Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Sales & Marketing | |
| HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
| REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| CORMEDIX INC. | Biotechnology | Chief Executive Officer | |
| World Health Organization /Europe/ | Corporate Officer/Principal | ||
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| POXEL | Pharmaceuticals: Major | Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Barnfin SA | Director/Board Member | ||
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| Lehigh University | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Graduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| FINANCIÈRE DE TUBIZE S.A. | Financial Conglomerates | Director/Board Member Director/Board Member | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| City University London | College/University | Undergraduate Degree | |
| Living Beyond Breast Cancer | Director/Board Member | ||
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Tufts University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
IDS Capital (UK) Ltd.
 IDS Capital (UK) Ltd. Investment ManagersFinance IDS Capital (UK) Ltd. is an investment arm of a single family office with roots in the chemical and biopharmaceutical sectors. IDS Capital (UK is based in London, UK, and is an authorized and regulated alternative investment fund manager and MiFID regulated firm since 2016, under the supervision of the Financial Conduct Authority. The British company focuses on investment solutions and opportunities through a diverse array of fundamental and quantitative strategies deployed by selected specialists worldwide. IDS Capital (UK aims to federate family offices around the sharing of investment opportunities, allowing for greater access and execution in all investment fields. The private company was founded in 2013 by Jonkheer Cédric van Rijckevorsel, who has been the CEO since then. | Investment Managers | Founder | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director of Finance/CFO | |
| UCB Pharma Sp zoo | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 31 |
| Royaume-Uni | 8 |
| Suisse | 5 |
| Belgique | 4 |
| France | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 209 |
| Corporate Officer/Principal | 127 |
| Independent Dir/Board Member | 54 |
| Chairman | 47 |
| Undergraduate Degree | 41 |
Relations les plus connectées
| Insiders | |
|---|---|
| David Epstein | 28 |
| Alice Dautry-Varsat | 26 |
| Julie McHugh | 26 |
| Jose-Carlos Gutiérrez-Ramos | 24 |
| Frederic Roch Doliveux | 21 |
| Peter John Fellner | 21 |
| Deborah Keller | 19 |
| Mohammed Khoso Baluch | 19 |
| Martyn D. Greenacre | 19 |
| John Hohneker | 18 |
| Robert E. Martell | 18 |
| Marc Rubin | 17 |
| Nancy Simonian | 15 |
| John D. Ratliff | 14 |
| Ann Thorell | 13 |
- Bourse
- Insiders
- Jonathan Zung
- Connexions Sociétés
